[Oral XXXX therapy in salpingitis].

@entity1 @entity2177 @entity344 @entity7553 @entity56 @entity4134 @entity2335
Thirty @entity1 with clinical @entity4134 were studied. Diagnosis was confirmed by laparoscopy. To determine the microbiological etiology, swab specimen for detection of aerobic, anaerobic and chlamydial infections were obtained from the endocervix, fimbriae and cul-de-sac. In 22 of 30 @entity1 , microorganisms were detected. The @entity1 received @entity2177 2 X 750 mg p.o. daily at 12 hours interval for 10 days. During and after therapy, bacteriological examinations of the endocervix were performed. Based on the microbiological evaluation and clinical aspects, the bacteriological response and clinical efficacy were 86%. Laboratory analysis showed no alterations of blood values. As side effects we noticed @entity344 (6/30), @entity7553 vulvovaginalis (6/30), @entity56 (5/30) and non-bacterial @entity2335 (2/30). Oral @entity2177 -monotherapy proved to be safe and effective in @entity4134 .
